SINGLETON J MATTHEW sold 62.7% of their position (16K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.27M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/25/2024ACC: 0000950170-24-117513
Director
Since Jan 2019
-16K
Net shares
Net seller
$1.27M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16K acquired · 32K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+16K
Price / share
$4.48
Trade value
$71.68K
% of position
168.4%
10/25/2024
9.50K→25.50K
Common Stock, par value $0.00001 per share
Direct
Shares
−16K
Price / share
$79.50
Trade value
$1.27M
% of position
62.7%
10/25/2024
25.50K→9.50K
Total
Net shares
+0.00
Net value
-$1.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 10/25/2024 | M · Option Exercise | +16K | $4.48 | $71.68K | 168.4% | 9.50K | 25.50K |
| Common Stock, par value $0.00001 per share Direct | 10/25/2024 | S · Sale | −16K | $79.50 | $1.27M | 62.7% | 25.50K | 9.50K |
| Total | +0.00 | -$1.20M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
16K shares
Shares
−16K
Strike price
4.48
Held after
0.00
Exercisable
—
10/25/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock16K shares | 10/25/2024 | M · Option Exercise | −16K | 4.48 | — | 0.00 |